Real-time enrollment status for this relapsed refractory multiple myeloma (rrmm) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:28 PM UTC
| NCT Number | NCT07032714 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Refractory Multiple Myeloma (RRMM) |
| Phase | Clinical Trial |
| Target Enrollment | 25 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | April 13, 2026 (Apr 13, 2026) |
As of July 13, 2026: Clinical trial NCT07032714 is currently recruiting participants. This clinical trial study for relapsed refractory multiple myeloma (rrmm) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07032714 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07032714 was last updated Apr 13, 2026 (April 13, 2026). HelloStudys verifies this status automatically.